Evidence map›Paper›PMID 30550638›Full record

ArticleJournal of tissue engineering and regenerative medicine2019

Optogenetic control of iPS cell-derived neurons in 2D and 3D culture systems using channelrhodopsin-2 expression driven by the synapsin-1 and calcium-calmodulin kinase II promoters.

Si-Yuen Lee, Julian H George, David A Nagel, Hua Ye, Gray Kueberuwa, Leonard W Seymour

Open access · hybridAbstract read
In one paragraph

Article in Journal of tissue engineering and regenerative medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 31 citations in OpenAlex.

  1. Review
  2. Protein design accelerates the development and application of optogenetic tools.Computational and structural biotechnology journal · 2025
    Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Optogenetic Control of Human Stem Cell-Derived Neurons.Methods in molecular biology (Clifton, N.J.) · 2022
    Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. New era of optogenetics: from the central to peripheral nervous system.Critical reviews in biochemistry and molecular biology · 2020
    Review
  15. Review
  16. Article
  17. Novel advanced patient-derivedFrontiers in neurology
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Si-Yuen LeeDepartment of Oncology, Old Road Campus Research Building, University of Oxford, Oxford, UK.ORCID 0000-0002-2503-2338
Julian H GeorgeInstitute of Biomedical Engineering, Old Road Campus Research Building, University of Oxford, Oxford, UK.ORCID 0000-0002-0701-5040
David A NagelSchool of Life and Health Sciences, University of Aston, Birmingham, UK.ORCID 0000-0002-9055-1775
Hua YeInstitute of Biomedical Engineering, Old Road Campus Research Building, University of Oxford, Oxford, UK.ORCID 0000-0001-7613-6041
Gray KueberuwaDepartment of Cancer Sciences, Manchester Cancer Research Centre, University of Manchester, Manchester, UK.ORCID 0000-0001-9066-0181
Leonard W SeymourDepartment of Oncology, Old Road Campus Research Building, University of Oxford, Oxford, UK.ORCID 0000-0003-3825-0841
University of Oxford · GBAston University · GBUniversity of Manchester · GB

Funding

Biotechnology and Biological Sciences Research Council BB/H008527/1Biotechnology and Biological Sciences Research Council BB/H008608/1Biotechnology and Biological Sciences Research Council (BBSRC) BB/H008527/1
6 · The paper itself

Abstract

Development of an optogenetically controllable human neural network model in three-dimensional (3D) cultures can provide an investigative system that is more physiologically relevant and better able to mimic aspects of human brain function. Light-sensitive neurons were generated by transducing channelrhodopsin-2 (ChR2) into human induced pluripotent stem cell (hiPSC) derived neural progenitor cells (Axol) using lentiviruses and cell-type specific promoters. A mixed population of human iPSC-derived cortical neurons, astrocytes and progenitor cells were obtained (Axol-ChR2) upon neural differentiation. Pan-neuronal promoter synapsin-1 (SYN1) and excitatory neuron-specific promoter calcium-calmodulin kinase II (CaMKII) were used to drive reporter gene expression in order to assess the differentiation status of the targeted cells. Expression of ChR2 and characterisation of subpopulations in differentiated Axol-ChR2 cells were evaluated using flow cytometry and immunofluorescent staining. These cells were transferred from 2D culture to 3D alginate hydrogel functionalised with arginine-glycine-aspartate (RGD) and small molecules (Y-27632). Improved RGD-alginate hydrogel was physically characterised and assessed for cell viability to serve as a generic 3D culture system for human pluripotent stem cells (hPSCs) and neuronal cells. Prior to cell encapsulation, neural network activities of Axol-ChR2 cells and primary neurons were investigated using calcium imaging. Results demonstrate that functional activities were successfully achieved through expression of ChR2- by both the CaMKII and SYN1 promoters. The RGD-alginate hydrogel system supports the growth of differentiated Axol-ChR2 cells whilst allowing detection of ChR2 expression upon light stimulation. This allows precise and non-invasive control of human neural networks in 3D.

Indexed as

OptogeneticsAlginatesAnimalsCalciumCalcium-Calmodulin-Dependent Protein KinasesCell Culture TechniquesCell DifferentiationCell LineCell SurvivalChannelrhodopsinsHuman Embryonic Stem CellsHumansInduced Pluripotent Stem CellsLentivirusMiceNeural Stem CellsAlginatesCalciumCalcium-Calmodulin-Dependent Protein KinasesChannelrhodopsinsSynapsins3D culturealginate hydrogelcalcium-calmodulin kinase IIchannelrhodopsin-2induced pluripotent stem cellneural tissue engineeringoptogeneticssynapsin-1

Identifiers

PMID30550638
PMCPMC6492196
OpenAlexW2903589333

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.